Cure lung fibrosis in China with Hong Kong Pharmaceutical Startup based in US
Fundraising campaign by
Anthony Szema
-
HK$0.00raised of HK$200,000.00 goal goal
No more donations are being accepted at this time. Please contact the campaign owner if you would like to discuss further funding opportunities
RDS2 Solutions (website rds2solutions.com) has co-invented a drug to cure lung fibrosis or scarring (human data indicating worse lung function in patients with low levels of the natural peptide called VIP, which is the main ingredient in our drug) and also has experimental efficacy in mice with bladder cancer metastatic to the lung.
We need $200,000 to fund pharmacokinetic and pharmacodynamic studies for a U.S. Food and Drug Administration pre-IND consult meeting prior to IND or Investigational New Drug (IND) status.
RDS2 solutions Hong Kong subsidiary intends to market this drug in China.
Rewards
Recognition at VIP Scientific Meeting at University of Hong Kong December 3, 2017
Organizer
- Anthony Szema
- Campaign Owner
No updates for this campaign just yet
